Systemic lupus erythematosus (SLE) is a complex, partially understood autoimmune disease that affects 300,000 Americans. In African-American women, SLE has been estimated to occur as frequently as 1 in every 250. African-Americans have a higher incidence and prevalence of lupus by about 3.5-fold compared to European-derived peoples. Understanding the mechanisms of lupus is imperative if we have any hope of finding therapies that will safely treat this disease. We cannot fully understand lupus without explaining its genetic architecture. Genes that alter risk are origins of disease causation and must be involved in disease pathogenesis. Many strategies are now available to discover these genes. Candidate gene approaches have given way to reverse genetics and the possibility of evaluating the entire genome has very recently undergone a technical scientific revolution providing the capacity to evaluate over 1 million markers per individual subject. In Project 2, we will evaluate the genomics of lupus in African-Americans by exploiting the new technologies and applying a genome-wide association scan in 1,400 cases and 400 controls on the Affymetrix 6.0 array. We will also have genotype data from an additional 1,000 African-American out-of-study controls already typed on the Affymetrix 6.0 array, giving us 80% power to detect odds ratios >1.38 when applying a threshold of p=5xl0E-8. We will further explore powerful hits in a large replication experiment of ~15,000 SNPs in 9,000 subjects of African-American, Hispanic and Asian descent. We will physically define the genomic interval containing the association effect using the trans-racial and fine mapping approaches. We will construct haplotypes and apply standard regression methods to identify and characterize genetic effects. We will use resequencing to identify novel variants. The candidate polymorphisms and their surrogates will be evaluated for genomic mechanism(s). When successfully completed this POI project will provide new genes with fundamental insights into the mechanisms by which lupus is generated. At the same time the infrastructure developed through this POI will provide the basis from which to evaluate compelling candidate genes important for lupus in minority populations.
Systemic lupus erythematosus (SLE) is a debilitating and often life-threatening disease, particulariy in African-Americans. Most progress to date has been in European populations. We have the opportunity with this P01 to better undersand lupus in African-Americans. The knowledge gained will form the basis for understanding the pathogenesis of this disorder, leading to new, safer, and more specific therapeutics.
|Sun, Celi; Molineros, Julio E; Looger, Loren L et al. (2016) High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet 48:323-30|
|Alarcón-Riquelme, Marta E; Ziegler, Julie T; Molineros, Julio et al. (2016) Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture. Arthritis Rheumatol 68:932-43|
|Deng, Yun; Zhao, Jian; Sakurai, Daisuke et al. (2016) Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Ann Rheum Dis 75:2007-2013|
|Lessard, Christopher J; Sajuthi, Satria; Zhao, Jian et al. (2016) Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans. Arthritis Rheumatol 68:1197-1209|
|Munroe, Melissa E; Lu, Rufei; Zhao, Yan D et al. (2016) Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheum Dis 75:2014-2021|
|Zhao, Jian; Giles, Brendan M; Taylor, Rhonda L et al. (2016) Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis 75:242-52|
|Taylor, Rhonda L; Cruickshank, Mark N; Karimi, Mahdad et al. (2016) Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells. Cell Mol Immunol 13:119-31|
|Liu, Ke; Kurien, Biji T; Zimmerman, Sarah L et al. (2016) X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis Rheumatol 68:1290-1300|
|Zhao, Jian; Wu, Hui; Langefeld, Carl D et al. (2015) Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. Clin Immunol 161:157-62|
|Martins, M; Williams, A H; Comeau, M et al. (2015) Genetic association of CD247 (CD3?) with SLE in a large-scale multiethnic study. Genes Immun 16:142-50|
Showing the most recent 10 out of 78 publications